Hengrui Therapeutics, Inc.
www.hengruitherapeutics.comPrinceton, NJ-based Hengrui Therapeutics, Inc. (HTI) is a U.S. biopharmaceutical company dedicated to developing and commercializing innovative drugs to address unmet medical needs. HTI’s current therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss in the pipeline.
Read more
Princeton, NJ-based Hengrui Therapeutics, Inc. (HTI) is a U.S. biopharmaceutical company dedicated to developing and commercializing innovative drugs to address unmet medical needs. HTI’s current therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss in the pipeline.
Read more
Country
State
New Jersey
City (Headquarters)
Princeton
Industry
Employees
11-50
Founded
2016
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Research and Development
Email ****** @****.comPhone (***) ****-****Vice President Pharmacovigilance
Email ****** @****.comPhone (***) ****-****Executive Director , Head of Clinical Operations and Project Management
Email ****** @****.comPhone (***) ****-****Executive Director
Email ****** @****.comPhone (***) ****-****
